SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-109391
Filing Date
2023-10-16
Accepted
2023-10-16 16:33:46
Documents
7
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2328383d1_6k.htm 6-K 9895
2 EXHIBIT 99.1 tm2328383d1_ex99-1.htm EX-99.1 46255
3 EXHIBIT 99.2 tm2328383d1_ex99-2.htm EX-99.2 106099
4 EXHIBIT 99.3 tm2328383d1_ex99-3.htm EX-99.3 10228
5 EXHIBIT 99.4 tm2328383d1_ex99-4.htm EX-99.4 12115
6 EXHIBIT 99.5 tm2328383d1_ex99-5.htm EX-99.5 105720
7 EXHIBIT 99.6 tm2328383d1_ex99-6.htm EX-99.6 87091
  Complete submission text file 0001104659-23-109391.txt   378485
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 231327670
SIC: 2833 Medicinal Chemicals & Botanical Products